Economy

The United States and The Fentanyl Drug Crisis

`)
}

});

} else {

$(‘.blur’).css({
‘background’: ‘linear-gradient(95deg, #4e4e4e 25%, #000 45%, #bbb 75%, #FFFFFF 100%) 98%/200% 100%’,
‘text-transform’: ‘inherit’,
‘-webkit-background-clip’: ‘text’,
‘background-clip’: ‘text’,
‘-webkit-text-fill-color’: ‘transparent’
})

$(“.wpb_content_element”).append(`

Want to read more?

Click on the button below to access all premium content
articles by purchasing one of our educational packages

GET PREMIUM

`)

}

});

The United States and The Fentanyl Drug Crisis

The United States is currently facing a severe drug crisis, mainly due to the use of Fentanyl and other opioids. Each week, over 1,500 Americans die from opioid use, making it the leading cause of fatal overdoses in the country. The national public health agency ‘The CDC’ reports that within a 12-month period ending in January 2022, there were more than 107,000 deaths in the US due to drug overdoses and poisonings. Of these, 67% were linked to synthetic opioids like fentanyl. Moreover, there has been a significant increase of over 56% in the rate of deaths involving synthetic opioids between 2019 and 2020, accounting for 82% of all opioid-related deaths in 2020.

You May Also Like

Economy

Gmatrixs ICO: Empowering Blockchain Game Development with New Solutions   The game industry has long recognized the importance of a robust game Publishing Platform,...

Editor's Pick

The Internet of Things (IoT) is becoming increasingly ubiquitous. Yet, with more devices connected, the opportunities for businesses to innovate and improve their operations...

Economy

Morpheus ICO: Streamlining Global Logistics with MRP Token Morpheus.Network, a pioneering blockchain-based platform, has set its sights on revolutionizing the logistics industry. The company...

Latest News

Ahead of a planned trip to China this week, U.S. Secretary of State Antony Blinken is reported to have alleged that Beijing is still...

Disclaimer: Greycardinalbussiness.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 Greycardinalbussiness.com

Exit mobile version